什么是 SEC Form 13F 申报?美股机构大户持股全攻略
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制,学会如何追踪顶级对冲基金与机构法人持仓动向。
CIK: 0001442756
申报总市值
US$11.7亿
US$11.7亿
74 檔
51.9%
Q3 2024 季度申报显示,PFM Health Sciences, LP 披露的美股组合总市值为 US$11.7亿,涵盖 74 个不同之权益投资仓位。
在 Q3 2024,PFM Health Sciences, LP 展现出较为审慎的避险与获利了结姿态。本季共减仓 25 个仓位并完全清仓 14 档持股,调降曝光的仓位数量高于加仓动作。
在资产配置集中度方面,PFM Health Sciences, LP 的前 5 大核心持股(包含 LLY, THC, CYTK 等)合计占整体申报市值的 51.9%,反映机构在主要关键仓位上的权重分布。
本季最大新建仓标的
INSP
市值: US$2075.1万
本季最大获利了结 / 清仓标的
QQQ
前期市值: US$8978.5万
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly & Co | 股票-医疗保健 | 14.99% | -1.48% | — | |
| 2 | THC | Tenet Healthcare CORP | 股票-医疗保健 | 5.55% | -4.83% | — | |
| 3 | CYTK | Cytokinetics Inc | 股票-医疗保健 | 5.26% | +1.40% | NEW | |
| 4 | ABBV | Abbvie Inc | 股票-医疗保健 | 4.52% | — | — | |
| 5 | VRTX | Vertex Pharmaceuticals Inc | 股票-医疗保健 | 3.92% | — | — | |
| 6 | ISRG | Intuitive Surgical Inc | 股票-医疗保健 | 3.82% | — | — | |
| 7 | MRK | Merck & Co. Inc. | 股票-医疗保健 | 3.49% | +1.40% | NEW | |
| 8 | HCA | Hca Healthcare Inc | 股票-医疗保健 | 2.88% | -0.49% | — | |
| 9 | UHS | Universal Health Services-b | 股票-医疗保健 | 2.78% | — | — | |
| 10 | MCK | Mckesson CORP | 股票-医疗保健 | 2.73% | — | — | |
| 11 | ARGX | Argenx Se - Adr | 股票-医疗保健 | 2.67% | +0.06% | — | |
| 12 | UNH | Unitedhealth Group Inc | 股票-医疗保健 | 2.50% | +1.72% | -37.96% | |
| 13 | ACHC | Acadia Healthcare Co Inc | 股票-其他 | 2.47% | +0.09% | +63.31% | |
| 14 | AXSM | Axsome Therapeutics Inc | 股票-医疗保健 | 2.38% | +0.54% | — | |
| 15 | TMO | Thermo Fisher Scientific Inc | 股票-医疗保健 | 2.05% | +0.57% | -8.20% | |
| 16 | DHR | Danaher CORP | 股票-医疗保健 | 1.98% | — | — | |
| 17 | XBI | Ss Spdr S&p Biotech ETF | ETF-科技型 | 1.90% | -5.30% | EXIT | |
| 18 | ICLR | ICON Public Limited Company | 股票-医疗保健 | 1.90% | +1.45% | — | |
| 19 | PEN | Penumbra Inc | 股票-医疗保健 | 1.83% | -2.56% | -10.18% | |
| 20 | HUM | Humana Inc | 股票-医疗保健 | 1.83% | +3.22% | NEW | |
| 21 | ELV | Elevance Health Inc | 股票-医疗保健 | 1.66% | — | +2.16% | |
| 22 | AMGN | Amgen Inc | 股票-医疗保健 | 1.65% | — | +11.43% | |
| 23 | ASND 2.25 04-01-28债券 | Ascendis Pharma A/s | 债券 | 1.52% | -1.54% | EXIT | |
| 24 | IQV | Iqvia Holdings Inc | 股票-医疗保健 | 1.50% | — | — | |
| 25 | EW | Edwards Lifesciences CORP | 股票-医疗保健 | 1.46% | +0.08% | -47.20% | |
| 26 | BDX | Becton Dickinson And Co | 股票-医疗保健 | 1.39% | — | -22.61% | |
| 27 | SYK | Stryker CORP | 股票-医疗保健 | 1.37% | +0.87% | -41.37% | |
| 28 | MOH | Molina Healthcare Inc | 股票-医疗保健 | 1.37% | — | — | |
| 29 | INSP | Inspire Medical Systems Inc | 股票-医疗保健 | 1.18% | — | — | |
| 30 | WAT | Waters CORP | 股票-医疗保健 | 1.04% | +0.85% | +148.59% | |
| 31 | OSCR | Oscar Health Inc - Class A | 股票-医疗保健 | 1.03% | +0.75% | — | |
| 32 | EPIEUR | Essa Pharma Inc | 股票-其他 | 0.94% | — | -7.50% | |
| 33 | ASND | Ascendis Pharma A/S | 股票-其他 | 0.77% | -3.64% | EXIT | |
| 34 | ERAS | Erasca Inc | 股票-其他 | 0.75% | +0.21% | NEW | |
| 35 | INSM | Insmed Inc | 股票-医疗保健 | 0.63% | — | -36.92% | |
| 36 | SRPT | Sarepta Therapeutics Inc | 股票-医疗保健 | 0.62% | — | — | |
| 37 | CELC | Celcuity Inc | 股票-其他 | 0.60% | +0.47% | NEW | |
| 38 | PRAX | Praxis Precision Medicines I | 股票-其他 | 0.60% | +0.07% | -59.60% | |
| 39 | ADAPY | Adaptimmune Therapeutics-adr | 股票-其他 | 0.54% | — | -4.94% | |
| 40 | BSX | Boston Scientific CORP | 股票-医疗保健 | 0.52% | — | -68.84% | |
| 41 | SRPT 1.25 09-15-27债券 | Sarepta Therapeutics Inc | 债券 | 0.50% | — | — | |
| 42 | CRBU | Caribou Biosciences Inc | 股票-其他 | 0.48% | -0.12% | +5.47% | |
| 43 | SNDX | Syndax Pharmaceuticals Inc | 股票-其他 | 0.46% | -0.30% | +9.44% | |
| 44 | HOWL | Werewolf Therapeutics Inc | 股票-其他 | 0.41% | — | +4.86% | |
| 45 | XENE | Xenon Pharmaceuticals Inc | 股票-其他 | 0.40% | — | +19.48% | |
| 46 | CON | Concentra Group Holdings Par | 股票-其他 | 0.38% | — | — | |
| 47 | KROS | Keros Therapeutics Inc | 股票-其他 | 0.33% | — | +202.95% | |
| 48 | ALKS | Alkermes plc | 股票-医疗保健 | 0.33% | — | — | |
| 49 | ITCIEUR | Intra-cellular Therapies Inc | 股票-其他 | 0.32% | — | -54.59% | |
| 50 | TGTX | Tg Therapeutics Inc | 股票-医疗保健 | 0.31% | — | — |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | THC | Tenet Healthcare CORP | +1.7% | — | 不变 |
| 2 | LLY | Eli Lilly & Co | +1.6% | — | 不变 |
| 3 | INSP | Inspire Medical Systems Inc | +1.2% | NEW | 新建仓 |
| 4 | ABBV | Abbvie Inc | +1.1% | — | 不变 |
| 5 | ACHC | Acadia Healthcare Co Inc | +1.1% | +63.31% | 加仓 |
| 6 | HCA | Hca Healthcare Inc | +0.9% | — | 不变 |
| 7 | ARGX | Argenx Se - Adr | +0.8% | — | 不变 |
| 8 | UHS | Universal Health Services-b | +0.8% | — | 不变 |
| 9 | ISRG | Intuitive Surgical Inc | +0.8% | — | 不变 |
| 10 | ASND | Ascendis Pharma A/S | +0.8% | NEW | 新建仓 |
| 11 | WAT | Waters CORP | +0.8% | +148.59% | 加仓 |
| 12 | CYTK | Cytokinetics Inc | +0.6% | — | 不变 |
| 13 | ASND 2.25 04-01-28债券 | Ascendis Pharma A/s | +0.5% | +27.78% | 加仓 |
| 14 | AXSM | Axsome Therapeutics Inc | +0.5% | — | 不变 |
| 15 | VRTX | Vertex Pharmaceuticals Inc | +0.5% | — | 不变 |
| 16 | DHR | Danaher CORP | +0.4% | — | 不变 |
| 17 | AMGN | Amgen Inc | +0.4% | +11.43% | 加仓 |
| 18 | CON | Concentra Group Holdings Par | +0.4% | NEW | 新建仓 |
| 19 | OSCR | Oscar Health Inc - Class A | +0.4% | — | 不变 |
| 20 | MOH | Molina Healthcare Inc | +0.3% | — | 不变 |
| 21 | IQV | Iqvia Holdings Inc | +0.3% | — | 不变 |
| 22 | TGTX | Tg Therapeutics Inc | +0.3% | NEW | 新建仓 |
| 23 | TMO | Thermo Fisher Scientific Inc | +0.3% | -8.20% | 减仓 |
| 24 | KROS | Keros Therapeutics Inc | +0.3% | +202.95% | 加仓 |
| 25 | VEEV | Veeva Systems Inc-class A | +0.2% | NEW | 新建仓 |
| 26 | ✓ | Longboard Pharmaceuticals In | +0.2% | NEW | 新建仓 |
| 27 | OCUL | Ocular Therapeutix Inc | +0.2% | NEW | 新建仓 |
| 28 | ERAS | Erasca Inc | +0.2% | +4.39% | 加仓 |
| 29 | PEN | Penumbra Inc | +0.2% | -10.18% | 减仓 |
| 30 | ELV | Elevance Health Inc | +0.2% | +2.16% | 加仓 |
| 31 | LUNG | Pulmonx CORP | +0.2% | NEW | 新建仓 |
| 32 | EPIEUR | Essa Pharma Inc | +0.2% | -7.50% | 减仓 |
| 33 | CRBU | Caribou Biosciences Inc | +0.2% | +5.47% | 加仓 |
| 34 | CAPR | Capricor Therapeutics Inc | +0.1% | NEW | 新建仓 |
| 35 | ARKG | Ark Genomic Revolution ETF | +0.1% | NEW | 新建仓 |
| 36 | XENE | Xenon Pharmaceuticals Inc | +0.1% | +19.48% | 加仓 |
| 37 | ICLR | ICON Public Limited Company | +0.1% | — | 不变 |
| 38 | ALKS | Alkermes plc | +0.1% | — | 不变 |
| 39 | PMVP | Pmv Pharmaceuticals Inc | +0.1% | +57.67% | 加仓 |
| 40 | SNDX | Syndax Pharmaceuticals Inc | +0.1% | +9.44% | 加仓 |
| 41 | ADAPY | Adaptimmune Therapeutics-adr | 0% | -4.94% | 减仓 |
| 42 | ✓ | Verve Therapeutics Inc | 0% | NEW | 新建仓 |
| 43 | HOWL | Werewolf Therapeutics Inc | 0% | +4.86% | 加仓 |
| 44 | BOLD | Boundless Bio Inc | 0% | +71.17% | 加仓 |
| 45 | INBX | Inhibrx Biosciences Inc | 0% | — | 不变 |
| 46 | SRPT 1.25 09-15-27债券 | Sarepta Therapeutics Inc | 0% | — | 不变 |
| 47 | IOVA | Iovance Biotherapeutics Inc | 0% | -13.51% | 减仓 |
| 48 | DAWNGBX | Day One Biopharmaceuticals I | — | -13.73% | 减仓 |
| 49 | IOBTQ | Io Biotech Inc | — | — | 不变 |
| 50 | GBIOGBX | Generation Bio Co | — | — | 不变 |
根据 SEC 官方 Form 13F 申报备案,PFM Health Sciences, LP 在 Q3 2024 季度的美股持仓总市值约为 US$11.7亿,共申报了 74 个公开持股仓位。
在 Q3 2024 季度,PFM Health Sciences, LP 按市值排列的前三大核心持股分别为:LLY (15.0%)、THC (5.5%)、CYTK (5.3%)。其中最大持股仓位 LLY 占据整体投资组合约 15.0% 的权重。
在 Q3 2024 季度中,PFM Health Sciences, LP 共进行了 63 项持仓异动,包含新建仓 11 个仓位、加仓 13 个仓位、减仓 25 个仓位以及清仓 14 个仓位。 其中最大新建仓标的为 INSP。 本季清仓仓位包含 QQQ。
本页面所有持股数据均直接同步自美国证券交易委员会(SEC)EDGAR 官方系统之 13F-HR / 13F-HR/A 季度申报文件。AlphaSMO 通过机器解析 CUSIP 与个股对照,提供 100% 精准对齐的历史时序数据集,并支持 Schema.org 结构化数据格式。
精选 AlphaSMO 大户持股与内部人交易深度分析,提升投资决策胜率
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制,学会如何追踪顶级对冲基金与机构法人持仓动向。
深入剖析 5% 股权申报门槛、13D 与 13G 之差异,以及最新 SEC 申报时程规范,洞察机构法人的激进投资动向。